כנס כאב ראש | 27-10-2022 | The 6th Annual International Headache Symposium

Greetings – Oved Daniel and Arieh Kuritzky

Molecular signaling pathways in migraine: update – Messoud Ashina

What to do when nothing works – Alex Mauskop

Variability in migraine epidemiology: lessons learned in southern Israel – Gal Ifergane

Connecting the line between dizziness, occipital headache, muscle tenderness and the cerebellum – Sait Ashina

Open-label studies: do they have any value? – Cristina Tassorelli

Psychedelic compounds for the treatment of headache disorders – Amnon Mosek

Dys-synchronization of alpha waves in migraine with aura: when the entire cortex is disorganized- Oved Daniel

Are there any predictors of response to migraine treatment? – Piero Barbanti

Efficacy of CGRP Modulators in Israel – Real World Data – Roni Sharon

Spontaneous intracranial hypotension – an update on diagnosis and management – Abraham Ashkenazi

Targeting CGRP receptor vs. ligand- which option is efficacious and safer in Migraine prevention? Nirit Lev

Differences and similarities between CGRP-mAbs and small molecule CGRP antagonists – Rami Burstein

A new era in the acute care and prevention of migraine – Alan Rapoport

Impact of anti-CGRP in patients with migraine: what the eye can’t see – Patricia Pozo

Open Discussion/Debate – All speakers